Claudia Krywiak
President & CEO @ Ontario Centre of Innovation
Toronto, Canada
Claudia Krywiak is a seed investor at Ontario Centre of Innovation in Toronto focused on Medical Device and Health Care. Claudia Krywiak
- Total investments:
- 11
- Last investment:
- Lead investor:
- 36%
Last updated:
For AI agents: llms.txt
Industries Claudia Krywiak invests in
Stages Claudia Krywiak invests in
Countries Claudia Krywiak invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical Device 4 (36%)
- Health Care 3 (27%)
- Medical 2 (18%)
- Biotechnology 2 (18%)
- Manufacturing 2 (18%)
Stage
- Seed 6 (55%)
- Pre-Seed 2 (18%)
- Grant 1 (9%)
- Series A 1 (9%)
- Convertible Note 1 (9%)
Country
- Canada 9 (82%)
- United States 2 (18%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Synakis patented a biodegradable hydrogel vitreous substitute that is injectable, non-cytotoxic in vitro and in vivo, low-swelling, stable, and optically transparent with a refractive index and density similar to those of the native vitreous. | $1.9M / Seed / May 11, 2026 | ||
| Mystoria offers a digital platform for fertility support, empowering users with tools and knowledge for reproductive health. | $365.7K / Seed / May 11, 2026 | ||
| Talin is a company that automates personalized candidate outreach and contact enrichment, streamlining the efforts of recruiters and recruitment agencies. Talin's AI-driven platform is revolutionizing staffing agency recruitment by automating key processes like lead generation and candidate outreach, enabling efficient operation scaling. | $573.7K / Pre-Seed / Oct 02, 2024 | ||
| Accelerating the ways we treat wounds today - from passive to rapid, & healthy wound management | $1.4M / Seed / Mar 11, 2024 | ||
| Noa Therapeutics is a preclinical biotech firm that is leading the way in the development of multimodal treatments. To simplify the course of care for patients in need, we developed a single, non-steroidal, small molecule with tunable efficacy | $1.6M / Pre-Seed / Mar 06, 2024 | ||
| Tenomix mission is to develop novel technologies that target inefficiencies in the pathology workflow optimize cancer care and reduce healthcare costs | $1.6M / Seed / Mar 01, 2024 | ||
| Evercloak is a manufacturer of ultra-thin graphene and other 2-d nanomaterial films designed for cleantech applications. The company's platform uses a low-cost advanced manufacturing platform which builds ultra-thin nanomaterial membranes, enabling disruptive clean technologies to reduce cost, energy use and associated greenhouse gas emissionsthroughout the oil and gas, nuclear, energy, mining and agri-food sectors. | $1.5M / Seed / Feb 13, 2024 | ||
| Novel Biotechnology operates as a biotechnology company and develops innovative solutions for plasmid DNA production. | $2.5M / Seed / Sep 27, 2023 | ||
| MIMOSA Diagnostics is the maker of the MIMOSA Pro, a handheld device that uses near-infrared light to accurately and non-invasively assess tissue health. It can be easily used by a patient or a caregiver, and the images produced will help inform the next steps within patient navigation and management | Convertible Note / Jul 17, 2023 | ||
| TROES is a Canadian company to develop smart power energy storage technologies, products, and solutions in a 170 Billion market to help middle-market project developers, power distributors, and power consumers to unlock numerous project opportunities with considerable payback which are not existed previously due to high project cost, lack ofexpertise and low development efficiency by using our patented modularized energy storage hardware and software. | Grant / Jun 16, 2023 | ||
| See all 11 investments → | |||
Co-Investors
Ontario Centre of Innovation provides a preeminent research-to-commercialization vehicle in Ontario
Ontario Centre of Innovation Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Claudia Krywiak
President & CEO
|
|||
Tanya Dunn
Executive Assistant to the President & CEO
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Claudia Krywiak invest in?
Claudia Krywiak invests primarily in Medical Device, Health Care and Medical startups, most often at Seed and Pre-Seed stage. Most of the 11 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Claudia Krywiak?
Public channels for Claudia Krywiak include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Claudia Krywiak last invest?
The most recent investment recorded for Claudia Krywiak closed in May 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
